ENDOMETRIAL HYPERTROPHY

This adverse event was reported 398 times

These drugs are most commonly taken by patients reporting ENDOMETRIAL HYPERTROPHY:

# Drug Count
0 TAMOXIFEN CITRATE 41
1 LEVONORGESTREL 33
2 MEDROXYPROGESTERONE ACETATE 26
3 ESTRADIOL 23
4 CONJUGATED ESTROGENS 21
5 ESTROGENS, CONJUGATED 21
6 LEVOTHYROXINE SODIUM 20
7 MIFEPRISTONE 19
8 ANASTROZOLE 17
9 SIMVASTATIN 16
See all common drugs associated with ENDOMETRIAL HYPERTROPHY

ENDOMETRIAL HYPERTROPHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Progestin Antagonist [EPC] 19 0.0040
1 Estrogen Agonist/Antagonist [EPC] 7 0.0027
2 Pyrethroid [EPC] 1 0.0006
3 Gonadotropin [EPC] 1 0.0005
4 Progesterone [EPC] 9 0.0004
5 Calcitonin [EPC] 1 0.0003
6 Estrogen [EPC] 56 0.0003
7 Aromatase Inhibitor [EPC] 30 0.0003
8 Potassium-sparing Diuretic [EPC] 3 0.0002
9 Barbiturate [EPC] 2 0.0002
See all drug classes enriched for association with ENDOMETRIAL HYPERTROPHY